Richter’s Uterine Fibroid Drug Esmya Hit By Liver Safety Concerns In EU

EU safety restrictions relating to liver toxicity concerns are likely to lead to changes to the labeling of Richter’s uterine fibroid product Esmya and to a sharp drop in the product’s sales. The moves could also affect the product in the US, where it was filed for approval last year.